Evidence map›Paper›PMID 28850581›Full record

ArticlePloS one2017

Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.

Matilu Mwau, Priska Bwana, Lucy Kithinji, Francis Ogollah, Samuel Ochieng, Catherine Akinyi, Maureen Adhiambo, Fred Ogumbo, Martin Sirengo, Caroline Boeke

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Matilu MwauCentre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.ORCID http://orcid.org/0000-0002-6754-7292
Priska BwanaCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Lucy KithinjiCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Francis OgollahCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Samuel OchiengCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Catherine AkinyiCentre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
Maureen AdhiamboCentre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
Fred OgumboCentre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
Martin SirengoNational AIDS and STIs Control Program, Ministry of Health, Nairobi, Kenya.
Caroline BoekeClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Kenya Medical Research Institute · KEClinton Health Access Initiative · USMinistry of Health · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe factors associated with mother-to-child HIV transmission (MTCT) in Kenya and identify opportunities to increase testing/care coverage.

designCross-sectional analysis of national early infant diagnosis (EID) database.

methods365,841 Kenyan infants were tested for HIV from January 2007-July 2015 and results, demographics, and treatment information were entered into a national database. HIV risk factors were assessed using multivariable logistic regression.

results11.1% of infants tested HIV positive in 2007-2010 and 6.9% in 2014-2015. Greater odds of infection were observed in females (OR: 1.08; 95% CI:1.05-1.11), older children (18-24 months vs. 6 weeks-2 months: 4.26; 95% CI:3.87-4.69), infants whose mothers received no PMTCT intervention (vs. HAART OR: 1.92; 95% CI:1.79-2.06), infants receiving no prophylaxis (vs. nevirapine for 6 weeks OR: 2.76; 95% CI:2.51-3.05), and infants mixed breastfed (vs. exclusive breastfeeding OR: 1.39; 95% CI:1.30-1.49). In 2014-2015, 9.1% of infants had mothers who were not on treatment during pregnancy, 9.8% were not on prophylaxis, and 7.0% were mixed breastfed. Infants exposed to all three risky practices had a seven-fold higher odds of HIV infection compared to those exposed to recommended practices. The highest yield of HIV-positive infants were found through targeted testing of symptomatic infants in pediatric/outpatient departments (>15%); still, most infected infants were identified through PMTCT programs.

conclusionDespite impressive gains in Kenya's PMTCT program, some HIV-infected infants present late and are not benefitting from PMTCT best practices. Efforts to identify these early and enforce evidence-based practice for PMTCT should be scaled up. Infant testing should be expanded in pediatric/outpatient departments, given high yields in these portals.

Indexed as

Antiretroviral Therapy, Highly ActiveAnti-HIV AgentsCross-Sectional StudiesDatabases, FactualFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalKenyaMothersNevirapinePregnancyPregnancy Complications, InfectiousRetrospective StudiesAnti-HIV AgentsNevirapine

Identifiers

PMID28850581
PMCPMC5574578
OpenAlexW2753107405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.